NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup.
about
Are we causing the recurrence-impact of perioperative period on long-term cancer prognosis: Review of current evidence and practiceR-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and MetastasisNovel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPasesPromising development from translational or perhaps anti-translational research in breast cancerThe Landscape of Randomised Controlled Trials of Therapies in Breast Cancer in Low and Middle Income Countries.Blocking Surgically Induced Lysyl Oxidase Activity Reduces the Risk of Lung Metastases.Bimodal mortality dynamics for uveal melanoma: a cue for metastasis development traits?Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancerKetorolac salt is a newly discovered DDX3 inhibitor to treat oral cancer.Cancer Recurrence and Regional Anesthesia: The Theories, the Data, and the Future in Outcomes.The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients.Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agentLymphadenectomy promotes tumor growth and cancer cell dissemination in the spontaneous RET mouse model of human uveal melanoma.DNA Damage in Healthy Individuals and Respiratory Patients after Treating Whole Blood In vitro with the Bulk and Nano Forms of NSAIDs.Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agentPerspectives in anaesthesia for cancer surgery.Concomitant resistance and early-breast cancer: should we change treatment strategies?Survivorship in untreated breast cancer patients.Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapy.Peri-operative biology in primary breast cancer: a credible therapeutic target.Treatment of advanced solid tumours with NSAIDs: Correlation of quantitative monitoring of circulating tumour cells and positron emission tomography-computed tomography imaging.Perioperative epidural analgesia reduces cancer recurrence after gastro-oesophageal surgery.The R-enantiomer of ketorolac delays mammary tumor development in mouse mammary tumor virus-polyoma middle T antigen (MMTV-PyMT) mice.Effects of surgery and anesthetic choice on immunosuppression and cancer recurrence.Neutrophil-lymphocyte ratio predicts response to chemotherapy in triple-negative breast cancer.Advances in antitumor effects of NSAIDs
P2860
Q26865763-97D9B250-FB27-4245-BFCF-402D9477CF22Q28265491-8B1847AA-5171-40A5-AEBC-A0F8C86979D3Q28550876-346C9881-FD7A-4CAC-BC0F-5E4DBF286ED6Q28709320-D1BB4DBD-557B-4F09-82E1-1D80933CAAE6Q33592950-9681B539-5913-43C6-9DEB-2A7D9648B6ACQ33628057-8124A98E-867E-43D3-BDF1-04269426258BQ33719777-8AB16349-4237-48A4-9391-62618035D6E1Q34337667-86E9CD12-2CBC-4B20-9DEE-CC3523922963Q35545634-6714D9D1-EF0A-4EA4-A712-2AB7B6E3C208Q35800595-A21822E0-2413-4C9F-BB97-803296A6AD7FQ35845330-AE02E61D-F68E-4C1B-A958-278507DCD2DAQ36483712-54FDC218-3108-4054-B59D-BAC7B6019AC2Q36689098-ED5B248F-39A8-4F97-B5E8-6C9D33DD7060Q37289997-6C4F52DB-BD26-4F6E-A7F3-6A22D45D9AFEQ37404693-BDB3EAE1-B540-47B7-91E1-F26AD1C8A8EEQ38146832-6B245E38-F1FE-41B0-8B98-182637C71FD5Q38171964-4721AEC7-5D91-471F-9995-74F5C273A4FAQ38318523-51233DD9-456C-4C60-937C-AA6C9CF96E44Q38635564-820B59C4-C19E-4ED1-AFB7-F76ABFF5286AQ38788375-F1F05E93-C7D3-43F3-A2BB-51261574CD30Q41182717-38741A3B-33A0-46C4-98A8-F3FD1FAB6209Q45100494-1373736D-CDDB-49A3-AE76-473DE8B7CEABQ45324338-BCEEF1B3-30B2-4D87-AF5E-B99EBE975F53Q49288734-4CEAAA46-FE05-4814-9FB3-ED49A9326E5EQ53069534-0CDB8F8F-3A57-4149-AE02-DA668832136CQ58561290-58C817F5-2EE3-4701-9029-EB66307D6405
P2860
NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
NSAID analgesic ketorolac used ...... e to triple negative subgroup.
@en
NSAID analgesic ketorolac used ...... e to triple negative subgroup.
@nl
type
label
NSAID analgesic ketorolac used ...... e to triple negative subgroup.
@en
NSAID analgesic ketorolac used ...... e to triple negative subgroup.
@nl
prefLabel
NSAID analgesic ketorolac used ...... e to triple negative subgroup.
@en
NSAID analgesic ketorolac used ...... e to triple negative subgroup.
@nl
P2093
P1476
NSAID analgesic ketorolac used ...... e to triple negative subgroup.
@en
P2093
Isaac Gukas
Jayant S Vaidya
Katharina Pachmann
Marc Dekock
Michael Baum
Michael Retsky
Rick Rogers
Romano Demicheli
William Jm Hrushesky
P2888
P304
P356
10.1007/S10549-012-2094-5
P407
P577
2012-05-24T00:00:00Z
P5875
P6179
1040019691